In vitro transcription. ssDNA oligonucleotides were ordered from Integrated DNA Technologies (IDT). RNA was either ordered from IDT or transcribed in vitro (Supplementary Table 1). Briefly, a partially dsDNA template with double-stranded T7 promoter region was created by incubating equimolar amounts of the DNA oligomers at 85°C and then placing them on ice. In vitro transcription (IVT) reactions (100 µL final volume) were carried out as follows: 1 µM DNA template, 50 mM TRIS pH 7.8, 30 mM MgCl2, 5 mM of each NTP (Jena Bioscience), 10 mM DTT, 2 mM Spermidine (Sigma-Aldrich), 0.1 U E. coli Inorganic Pyrophosphatase (NEB), and 0.5 µM of homemade T7 polymerase (purified from a recombinant source in our laboratory). The reaction was incubated at 37°C for 4–6 hours. After column purification (Monarch RNA Cleanup Kit, NEB), the transcribed RNAs were gel purified after 12–20% PAGE. The transcript band was visualized by UV shadowing on a TLC plate, excised, crushed in a 2 mL tube with a syringe plunger and soaked overnight in 2 v/w of 0.3M NaOAc pH 5.2 at 4°C on a rotator. Gel debris was removed by spin filtration in 0.45 µm Spin-X cellulose acetate filters (Costar) for 2 minutes at 17,000 g, 4°C. The eluted RNA was precipitated in 1.2 volumes of cold isopropanol, cooled 45–60 minutes at -20°C and centrifuged for 90 minutes at 21,000 g, 4°C. The supernatant was discarded and the pellet was washed with 1 mL of 80% ethanol and centrifuged another 20 minutes at 21,000 g, 4°C. The pellet was suspended in ultrapure water and quantified on a Nanodrop measuring absorbance at 260 nm using their specific extinction coefficient calculated using OligoCalc (http://biotools.nubic.northwestern.edu/OligoCalc.html).
Synthesis of FQ-B Substrate. TAMRA-NHS-Ester was bought from Sigma. gamma-aminohexyl-GTP was bought from Jena Bioscience. A 5’-phosphorylated pentamer with a 3’-end quencher (BHQ2) was ordered from IDT. The substrate was first in vitro transcribed with the modified initiator nucleotide. The reaction differed from the IVT described above by having 6 mM ATP, UTP and CTP, 2 mM GTP, and 4 mM gamma-aminohexyl-GTP. The resulting RNA was column purified (Monarch RNA Cleanup Kit) and reacted with the TAMRA-NHS-ester according to manufacturer’s instructions. Briefly, around 60 ODs of the 5’ aminohexyl RNA was dried under vacuum and resuspended in 600 µL sodium tetraborate pH 8.4 then combined with 100 µL of TAMRA-NHS-ester in DMSO at 10 µg/µL of fluorophore and incubated for 4 hours in a dry block at 25°C, 600 rpm. The RNA was precipitated in 1.2 volumes of isopropanol, washed once with 80% ethanol, resuspended in ultrapure water and quantified on a Nanodrop as described above. Subsequently, the fluorophore-tagged RNA was ligated to the 3’ quencher-tagged pentamer with T4 RNA ligase 2 (NEB) and a DNA splint complementary to the 15 nucleotides from the 3’-end. The reaction setup (200 µL – 1 mL) was as follows: 3 µM of TAMRA-B, 3.5 µM Pentamer, 3.5 µM DNA splint, 8% DMSO, 1X T4 RNA ligase 2 buffer, 9 mM MgCl2, 100 µM ATP, 50 U T4 RNA ligase 2, 15% PEG8000. The nucleic acids were mixed with water and DMSO, heated to 85°C and placed on ice for annealing. The remaining reagents were added in the order listed. The reaction was incubated at 25°C for 1 hour, then at 16°C for 16 hours. After isopropanol precipitation, the pellet was suspended in Formamide and gel purified on a 20% PAGE. Recovery and quantification of RNA was as described above.
Preparation of GUVs for microscopy. POPC lipids dissolved in chloroform were added to a glass vial containing chloroform to obtain 250 µL of a 6 mM solution. Fluorescent GUV membranes were obtained by adding 0.5 µL of a 1 mg/mL solution of Atto 647N-DOPE lipids in chloroform (~ 0.03 mol%). The chloroform was evaporated under nitrogen flow (10 min) and the lipids were dried under reduced pressure for 1 h to remove residual traces of chloroform. A lipid-mineral oil solution (400 µM lipids) was prepared by adding 3 mL of mineral oil to the dried lipids followed by sonication for 1 h at elevated temperature (40–60°C). 750 µL of lipid-mineral oil solution was layered on top of 2 mL of outer phase solution in a 5 mL Eppendorf tube. Incubation for 15 min at RT allows lipid monolayer formation at the water-oil interface. Meanwhile, 750 µL of lipid-mineral oil solution and 15 µL of inner phase solution were combined in a 1.5 mL Eppendorf tube. A water-in-oil emulsion was generated by rubbing the tube over an Eppendorf rack. The water-in-oil emulsion was immediately and carefully pipetted to the biphasic mixture in the 5 mL Eppendorf tube. To generate lipid GUVs, gradual centrifugation (10 min at 300 g followed by 2.5 min at 1500 g) was performed to push the denser inverse micelles (surrounded by a lipid monolayer) through the interfacial lipid monolayer. Vesicle pellets at the tube bottom were visible by eye and could thus be easily taken up with a pipette. A 384-glass bottom microtiter plate was first passivated with 50 µL of a Pluronic F-127 solution (10 mg/mL) and then washed once with 50 µL of outer phase solution. Next, the pellet and outer phase solution (~ 50 µL) were transferred to the plate. Another GUV population was added and mixing of both populations was achieved by gently pipetting up and down (10 times). Before freeze-thawing, the plate was centrifuged for 5 min at 1500 g for GUV accumulation and high GUV densities. All steps including mineral oil were performed in a custom-made glove box under reduced humidity (< 10% relative humidity) except for the centrifugation step for GUV formation.
Freezing and thawing of well plate for microscopy. Freezing and thawing was performed at high cooling and low heating rates for all experiments. Before sample freezing, glass bottom microtiter plates were sealed with the aluminium-coated sealing film ROTALIBO®. A block made of stainless steel pre-cooled in a -80°C freezer was pressed against the glass bottom leading to sample freezing within a few seconds. Plates were then stored at -80°C for up to 30 min, taken out and thawed at RT while holding them at an angle to avoid GUV dispersal, thus maintaining high GUV densities required for an efficient content exchange. In time-lapse experiments (Supplementary Fig. 14b-d), plates remained attached to the microscope stage during freeze-thawing. Here, fast-freezing was achieved by liquid nitrogen poured into the wells surrounding the sample well. Condensation on the glass bottom was avoided by blowing in N2 gas from below to enable sample access at sub-zero temperatures with a dry objective. Sample thawing at RT started once the liquid nitrogen was fully evaporated.
Preparation of GUVs for PAGE assays with freezing and thawing. POPC lipids dissolved in chloroform were dried under nitrogen flow, and placed under vacuum for 1 hour to remove traces of chloroform. The dried lipids were subsequently dissolved in light mineral oil (Carl Roth) to obtain a final concentration of 400 µM, incubated at 60°C for 5 minutes then vigorously vortexed for 1 minutes, and finally sonicated for 1 hour at 40–60°C in a water bath to disperse aggregates and completely resuspend dried lipids. Next, 1.5 mL tubes were prepared with 600 µL of outer phase containing ribozyme buffer (as specified per experiment) and 900 mM glucose, layered with 300 µL of lipids in oil suspension and was allowed to rest for 30 minutes to properly form the lipid monolayer at the oil-water interface. The emulsion was prepared by adding 24 µL inner phase solution (containing 900 mM sucrose) to 400 µL of lipids in oil solution and mechanically agitating the tube over a tube rack until the suspension turned milky white. The emulsion was carefully transferred to the oil layered on the outer phase, and spun at 300 g for 5 minutes. The vesicle pellet was recovered by piercing the bottom of the open tube with a needle and ejecting it into a clean tube by closing the cap. GUV populations were united, 700 µL fresh glucose outer phase was added and the vesicles were spun at 2000 g for 5 minutes. Most of the supernatant was discarded. The pellet was resuspended in ~ 25 µL buffered glucose outer phase, and 10 µL samples were placed in PCR tubes and spun again at 2000 g for 5 minutes to form a vesicle pellet. Control samples were held at room temperature (RT) and the rest were subjected to cycles of freezing and thawing as follows: 5 minutes in aluminum block at -80°C, 5 minutes at room temperature, and incubation at the desired reaction temperature. When mentioned, the freeze thaw cycle was applied multiple times.
RNA recovery from GUVs and PAGE analysis. To recover the encapsulated RNA from GUVs and analyze activity via polyacrylamide gel electrophoresis, the following protocol was employed: samples of 5–10 µL were added to 500 µL of unbuffered glucose outer phase, mixed by inverting the tube and spun at 2000 g for 5 minutes. 450 µL of supernatant was then replaced with an equal volume of fresh glucose outer phase. This wash step serves to exchange the outer phase and remove any biomolecules or salts that leaked from GUVs into the outer phase. After exchanging the outer phase, the GUVs were pelleted by spinning at 2000 g for 5 minutes, the supernatant was discarded leaving only around 10 µL of pellet, and 10–20 µL of GUV loading buffer was added (containing 25 mM EDTA, 0.3% Triton X-100, 0.01% bromophenol blue, 95% formamide) and vortexed vigorously for 5–10 seconds. Finally, the samples were denatured by incubating for 5 minutes at 85°C and placed on ice. A few microliters were then loaded on a 12–20% denaturing urea-PAGE and run for 60 minutes at a constant 25 W. Gels were imaged immediately after the run on the Azure RGB Sapphire and analyzed using the Azure Spot software.
Hammerhead assay in solution. Reactions were carried out in volumes of 50 µL. Substrate cleavage was monitored in a reaction containing 5 µM hammerhead ribozyme, 2.5 µM Cy5-tagged substrate in hammerhead buffer that consisted of 20 mM Tris-HCl pH 8.3, 900 mM sucrose, and 4 mM MgCl2. The reaction was set up on ice and started by the addition of MgCl2 and incubating at 25°C. Samples were taken at specific time points by quenching 5 µL of reaction with 20µL of hammerhead loading buffer containing 10 mM EDTA, 0.01% bromophenol blue, 98% formamide and placed on ice. After all samples were collected, they were denatured at 85°C for 5 minutes and cooled quickly on ice before loading onto a 20% denaturing urea-PAGE. Gel imaging and analysis were performed as described above. Data was fitted to an exponential plateau function on GraphPad Prism.
Hammerhead assay in GUVs for microscopy. Two GUV populations encapsulating the hammerhead buffer (900 mM sucrose, 20 mM Tris-HCl pH 8.3, 4 mM MgCl2) were prepared and combined in a 1:1 ratio as described above. One population contained the substrate (HH-FQ-sub − 2.5 µM) and the other membrane-labelled population contained either minimal hammerhead ribozyme (HH-min − 5 µM), the mutated ribozyme (HH-mut − 5 µM) or no ribozyme (negative control - NC). The outer phase consisted of hammerhead buffer and 900 mM of glucose to ensure both a density gradient and isosmotic conditions between inner and outer phase. Sample freezing and thawing was applied as described above. Images were taken at RT before and after freeze-thawing.
Hammerhead assay in GUVs with PAGE analysis. GUVs encapsulating the hammerhead ribozyme were prepared as described above with the hammerhead buffer (900 mM sucrose, 20 mM Tris-HCl pH 8.3, 4 mM MgCl2) and 5 µM hammerhead ribozyme. Substrate GUVs were also prepared the same way except that it included 2.5 µM Cy5-tagged substrate RNA instead of the ribozyme. The outer phase was the hammerhead buffer but with 900 mM of glucose rather than sucrose, which is necessary for the density gradient. The two GUV populations were united and washed once with 700 µL of buffered outer phase followed by spinning at 2000 g for 5 minutes. The volume was reduced to ~ 25 µL and split into two samples of 10 µL each. One sample was a control held at room temperature while the other was subjected to a cycle of freezing and thawing. Both samples were subsequently incubated at 37°C for 1 hour before the GUVs were washed, the RNA was recovered from the GUVs and analyzed by 20% PAGE, as described above.
R3C ligase assay in GUVs for microscopy. GUVs encapsulating the R3C buffer (900 mM sucrose, 50 mM EPPS pH 8.5, 20 mM MgCl2) were prepared as described above. One population was membrane-labelled and contained the ribozyme rt-F, the other contained the substrates rt-A-short and FQ-B. Ribozyme and substrates were encapsulated at varying concentrations in two experimental approaches. Concentrations were either 20/15/10 µM or 5/5/2 µM (rt-F/rt-A-short/FQ-B, respectively). The outer phase consisted of 900 mM of glucose and R3C buffer. Freezing and thawing was implemented as described above. Images were taken at RT before and after freeze-thawing. Further images were taken after a subsequent 1 h incubation at 37°C.
R3C autocatalytic ligase assay in solution. To determine the activity of the R3C ligase ribozyme in vitro, only the Cy5-tagged inactive A substrate was used as a reporter for ligation yields. 10 µL reactions were prepared on ice, with 5 µM Cy5-A.,7.5 µM B, and varying concentrations of either ribozyme F1 or the unmodified substrate Hyper-A. The R3C buffer consisted of 50 mM EPPS pH 8.5, 900 mM sucrose, and 20 mM MgCl2. The reaction was started by the addition of MgCl2 and incubating it at 42°C. Samples were consistently taken at specific time points by quenching 1 µL of the reaction with 9 µL of R3C RNA loading buffer (containing 25 mM EDTA, 95% formamide and 0.01% bromophenol blue) and placed on ice. After all samples were collected, they were denatured at 85°C for 5 minutes and immediately placed on ice, before loading onto a 12% denaturing urea-PAGE. Gel imaging and analysis were performed as described above. The data points of the ribozyme F were fitted to an exponential plateau function while the data points of the Hyper-A substrate were fitted to an exponential growth function on GraphPad Prism.
FT-dependent activity of R3C ligase. The different GUV populations were prepared independently as described above. Briefly, ribozyme GUVs encapsulated 1 µM of ribozyme F1 in R3C buffer (50 mM EPPS, 20 mM MgCl2, 900 mM sucrose), substrate A GUVs contained a mixture of 9 µM Hyper-A and 1 µM Cy5-A in R3C buffer, substrate B GUVs encapsulated 15 µM of B in R3C buffer, empty GUVs were used as a negative control and contained only R3C buffer with no RNA. The outer phase also contained the R3C buffer but with 900 mM glucose instead of sucrose. The GUV populations were combined in a 1:1:1 ratio to obtain a starting sample with both substrate vesicles and either ribozyme GUVs or empty GUVs as the control. The GUVs were washed once with 700 µL buffered glucose outer phase and centrifuged at 2000 g for 5 minutes. The supernatant was discarded, and the pellet was resuspended in ~ 25 µL buffered glucose outer phase. 10 µL samples were aliquoted in PCR tubes and subjected to different numbers of FT cycles (none, one, two or three successive cycles) followed by a 1-hour incubation at 42°C. Samples were subsequently washed twice in 500 µL unbuffered glucose and prepared for 12% denaturing urea PAGE as described above.
Serial dilution of autocatalytic R3C ligase GUVs. The GUV populations were prepared as above, but a population of only substrate vesicles (both A and B) was also prepared, to be used as a fresh feedstock. After GUV populations were combined (1:1:1), washed and centrifuged, they were subjected to 3 FT cycles, followed by a 1-hour incubation period at 42°C. Then, settled GUVs were resuspended, a 5 µL sample was taken and washed in 500 µL unbuffered glucose outer phase twice and subsequently resuspended in 10 µL of the GUV loading buffer. To the remaining 5 µL of GUVs, 5 µL of fresh substrate GUV feedstock was added. The new generation was centrifuged at 2000 g for 5 minutes to pellet the GUVs and subjected again to 3 FT cycles followed by incubation. This process was repeated for several generations. After all generations were sampled, they were heat denatured and loaded on a 12% denaturing urea-PAGE and analyzed as above. Data points were fitted to a single exponential decay function on GraphPad Prism for descriptive purposes.
Laser scanning confocal fluorescence microscopy. All images were taken on a laser scanning microscope LSM 780 (Carl Zeiss, Germany) equipped with a water immersion objective (C-Apochromat 40 x / 1.20 W) for acquisition at room temperature before and after FT, or a dry objective (Plan-Apochromat 40 x / 0.95) for time-lapse imaging during FT-cycling. Samples were excited at 488 nm for FAM / Atto-488, 561 nm for TAMRA/Alexa Fluor-568 excitation and 633 nm for Atto-647N. At room temperature, colours were excited separately to avoid cross-talk whilst time-lapse experiments required simultaneous illumination. Images were typically recorded using a 1 airy unit pinhole, a resolution of 512 x 512 pixels and pixel dwell times ranging from 12–25 µs. Time-lapse imaging was typically performed with 3 µs pixel dwell times and 1 s intervals. For tile-scan imaging, a group of individual adjacent image fields (tiles) was recorded and stitched together by the Zeiss software (Zen Black, v13.0.2.518).
Image analysis. All confocal images shown were analysed using Fiji (v1.53c). For visual presentation, images were merged from separately recorded channels and adjusted for brightness and contrast. Brightness and contrast adjustments were applied homogenously for all acquired images. Image stacks derived from time-lapse experiments were analysed by defining regions of interest using the built-in ROI manager. Data processing and plotting was performed using OriginPro (2020b, v9.7.5.184).